NOTICE OF UPGRADE

Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022

InvestoGain Australia
 

SEARCH LISTED COMPANY


Any AUS or NZ company

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH PRIVATE COMPANY


SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED (MVP)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

 

Shareholder links

Our website ranking of MVP: rating 4
(4 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Computershare Melbourne
Yarra Falls, 452 Johnston Street, Abbotsford VIC 3067
Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 3 9473 2500
RegistryWebsite RegistryEmail

Company details

ISIN: AU000000MVP2
Address: Suite 7, 56 Smith Road, SPRINGVALE, VIC, AUSTRALIA, 3171
Tel:  (03) 9547 1888Fax: (03) 9547 0262

Date first listed: 15/12/2003

Sector: Pharmaceuticals & Biotechnology Industry Group: XHJ
Activities: Designs, manufactures and distributes a wide range of equipment, products and devices in the anaesthetics, oxygen delivery, veterinary and asthma management fields - also manufactures a pre-hospital and emergency pain relief product which is widely used i

News & Events

Expand this box to read and print

The suspension of trading in the options of Medical Developments International will be lifted immediately.

02/09/2022

The company releases the Table of Top 20 Option Holders and Spread of Option Holders.

01/09/2022

The company releases a notice of application for quotation of securities.

31/08/2022

The company has successfully completed the retail component of the fully underwritten 1 for 9.5 pro rata accelerated non-renounceable entitlement offer of new fully paid shares in MVP together with 1 option for every 2.5 new shares issued under the entitlement offer.

30/08/2022

The options of Medical Developments International Limited will be suspended immediately in accordance with Listing Rule 17.3, as there will be no deferred settlement trading. The options are expected to be quoted on a normal settlement basis on Friday, 2 September 2022. The suspension only applies to MVP's options, and does not apply to any other quoted securities of MVP.

26/08/2022

listed entity carried for record purposes only

01/07/2004

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...

     


     

    Click here for free access to this company's:
    ASX, Legal & CGT Status

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    03/04/2024Russell Basser15,873$0.615$9,762
    07/09/2023Gordon Naylor56,000$0.885$49,560
    26/11/2021Gordon Naylor62,000$4.940$306,280
    25/11/2021Gordon Naylor38,505$4.902$188,732
    03/09/2021Max Johnston5,700$3.500$19,950

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Gordon NaylorNon Exec Chairman14/10/2020
    Brent MacGregorCEO01/11/2020
    Anita JamesCFO27/05/2022
    Leon HoareNon Exec Director27/09/2013
    Mary SontropNon Exec Director05/03/2021
    Christine EmmanuelNon Exec Director26/05/2020
    Richard BettsNon Exec Director11/05/2021
    Russell BasserDirector01/09/2023
    Tara EatonCompany Secretary

    Date of first appointment, title may have changed.

    SPECIAL NOTE: During May 2024 we are working to remove duplications in the Company Secretary role.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    David WilliamsNon Exec Director16/09/200326/04/2023
    Max JohnstonIndependent Director05/11/201227/10/2022
    Mark EdwardsCFO27/05/2022
    Philip PowellNon Exec Director17/12/201429/10/2021
    John SharmanCEO12/04/201005/03/2020
    Harry OxerDirector28/12/200618/12/2018
    Allan McCallumNon Exec Director27/11/200317/12/2018
    Maurice van RynDirector27/11/200328/07/2014
    Iain KirkwoodDirector27/11/200326/02/2013
    Anthony CoulepisDirector13/07/200524/10/2012

    Date of first appointment, title may have changed.